NELNET INC
NNIBusiness Summary
Nelnet is an operating holding company with primary businesses in consumer lending, loan servicing, payments, and technology-enabled services, many of which are focused on serving customers in the education sector. The Company conducts these activities both directly and through its wholly owned and majority-owned subsidiaries, and actively manages and operates its businesses on an integrated basis. A significant portion of the Company's revenue is derived from net interest income earned on a portfolio of federally insured student loans. The Company has also broadened its operating business mix both within and beyond its historical education-focused activities, including banking, asset management, real estate, reinsurance, renewable energy development, and selected strategic interests in early-stage, emerging growth, and other operating enterprises. The Company earns substantially all of its revenue from external customers in the United States, and substantially all of its long-lived assets are located in the United States.
The Department of Education is the Company's largest customer, representing 21% of the Company's revenue and 68% of the LSS operating segment's revenue in 2025. The Company believes its scalable servicing platforms allow it to provide compliant, efficient, and reliable service at a low cost, giving the Company a competitive advantage over others in the industry. NDS is one of the leaders in the development of servicing software for guaranty agencies, consumer and private education loan programs, the Federal Direct Loan Program, and FFELP student loans. The Company is the largest provider of tuition management and financial needs assessment services to the private and faith-based K-12 market in the United States. The Company believes its principal competitive advantages are the customer service it provides, the technology provided with its service, and its ability to integrate its technology with institution clients and their third-party service providers.
The Company earns fee-based revenue through its Loan Servicing and Systems (NDS) and Education Technology Services and Payments (NBS) reportable operating segments. The Company earns net interest income on its loan portfolio, consisting primarily of FFELP loans, through its Asset Generation and Management (AGM) reportable operating segment. Nelnet Bank operates as an internet industrial bank franchise focused on the private education and unsecured consumer loan markets. The Company also generates revenue from reinsurance premiums, solar construction, investment advisory services, and other activities. The Company actively works to maximize the amount and timing of cash flows generated from its FFELP portfolio and seeks to acquire additional loan assets to leverage its servicing scale and expertise.
The Loan Servicing and Systems (LSS) operating segment focuses on student and consumer loan servicing, loan servicing-related technology solutions, and outsourcing business services. As of December 31, 2025, the Company serviced $486.2 billion of loans for 13.2 million borrowers. LSS revenue was $509.1 million for the year ended December 31, 2025, compared to $482.4 million in 2024. Government loan servicing revenue was $364.0 million in 2025, down from $380.9 million in 2024, while private education and consumer loan servicing revenue increased to $94.5 million from $63.5 million. The Education Technology Services and Payments (ETSP) operating segment provides education and payment technology and services for K-12 schools, higher education institutions, and businesses. ETSP revenue was $507.2 million in 2025, up from $487.0 million in 2024. FACTS generated $312 million in revenue in 2025, Nelnet Campus Commerce generated $148 million, Nelnet Payment Services generated $64 million, and Nelnet International generated $9 million.
The Asset Generation and Management (AGM) operating segment includes the acquisition, management, and ownership of the Company's loan assets. As of December 31, 2025, AGM's loan portfolio was $8.7 billion, with 85.5% federally insured. AGM also derives revenue by providing loan administration services to third-party loan portfolio owners. Nelnet Bank offers refinance and in-school private education loan options and unsecured consumer loans. As of December 31, 2025, Nelnet Bank's loan portfolio was $957.6 million and its investment portfolio was $1.08 billion. Nelnet Bank had $1.76 billion of deposits as of December 31, 2025. The Nelnet Insurance Services operating segment had 5 treaties that reinsure risk on approximately 80 different insurance programs issued by 5 carriers as of December 31, 2025. Whitetail Rock Capital Management had $3.3 billion in assets under management for third-party customers as of December 31, 2025. The Company held ownership interests in 55 real estate properties with a carrying value of $233.2 million as of December 31, 2025.
In June 2025, ALLO redeemed all of Nelnet's outstanding preferred membership interest and more than 50% of Nelnet's voting membership interest, with Nelnet receiving cash proceeds of $410.9 million and recognizing a pre-tax gain of $175.0 million. The Company sold Nelnet Renewable Energy (NRE) in November 2025. In July 2025, the Company sold $203.3 million of consumer loans to an unrelated third party. In August 2025, the Company redeemed a portion of its interest in CompanyCam and received cash proceeds of $10.1 million, recognizing a pre-tax gain of $7.8 million, and also recognized a pre-tax gain of $22.4 million to adjust its carrying value of its remaining interest. On February 2, 2026, the Company acquired a Canadian student loan servicing business for CAD $130.5 million (USD $95.7 million). The Company repurchased 566,575 shares of Class A common stock for $69.3 million during 2025. The Company paid quarterly cash dividends totaling $1.19 per share in 2025.
GAAP net income attributable to Nelnet, Inc. was $428.5 million for the year ended December 31, 2025, compared to $184.0 million in 2024. Non-GAAP net income attributable to Nelnet, Inc., excluding derivative market value adjustments, was $435.4 million in 2025 versus $176.4 million in 2024. Total interest income was $851.5 million in 2025, down from $973.4 million in 2024, while net interest income increased to $354.5 million from $292.9 million. Total other income was $1.40 billion in 2025, up from $1.17 billion in 2024. Income before income taxes was $526.3 million in 2025, compared to $228.6 million in 2024. The effective tax rate was 23.00% in 2025 and 22.25% in 2024.
Business Outlook
The Company expects its 2026 effective tax rate will range between 22.5% and 24.5%. The Company plans to continue making regular quarterly dividend payments, subject to future earnings, capital requirements, financial condition, and other factors. The Company's Board of Directors has declared a first quarter 2026 cash dividend of $0.33 per share.
The Company is actively expanding its private education and consumer loan portfolios, or residual interests therein, and as part of this strategy launched Nelnet Bank in 2020. During 2025, the Company purchased $629.7 million of consumer and other non-FFELP loans (excluding Pay Later receivables). The Company began to purchase Pay Later receivables via a forward flow agreement during 2025, and as of December 31, 2025, the balance of Pay Later receivables was $744.2 million. The Company plans to fund additional loan acquisitions through a combination of current cash, cash generated from operating activities, expected future cash flows from loan securitizations, proceeds from the sale of certain investments, borrowings under its unsecured line of credit, and other facilities. The Company believes there are opportunities to increase its customer base and revenues internationally through its Nelnet International division, which provides services primarily in Australia, New Zealand, and Southeast Asia.
The Company is actively acquiring consumer and other non-FFELP loans or residual interests therein and plans to expand these portfolios to diversify its asset base. The Company's venture capital team manages a diversified portfolio comprising partial ownership in approximately 110 operating companies and 45 funds, with an aggregate carrying value of $326.9 million as of December 31, 2025. The Company expects its current solar partnerships (assuming no additional contributions are made subsequent to December 31, 2025) to generate approximately $123 million of pre-tax earnings (excluding noncontrolling interests) over the life of the solar partnerships, and expects to recognize approximately $198 million in pre-tax income (excluding noncontrolling interests) on such solar partnerships between January 1, 2026 and June 30, 2031.
The Company's core loan spread for the AGM operating segment improved to 1.48% in 2025 from 0.97% in 2024. Variable loan spread was higher during 2025 compared with 2024 due to an increase in consumer loans as a percentage of AGM's overall loan portfolio and an increase in loans funded by the Company with operating cash. The Company expects its 2026 effective tax rate will range between 22.5% and 24.5%. Operating costs in the LSS segment declined as a result of migrating to one government servicing platform in 2024 and the continued execution of cost-saving initiatives, including process optimization, technology enhancements, and the expanded use of AI.
The Company sold NRE in November 2025, and although it retained a limited number of construction contracts to complete following the sale, the Company does not expect the operating results from such contracts to be significant in future periods. The Company has a $495.0 million unsecured line of credit that matures on September 22, 2026. As of December 31, 2025, there was no amount outstanding on the unsecured line of credit and $495.0 million was available for future use. The Company intends to use its current and future liquidity position to capitalize on market opportunities, including FFELP, private education, consumer, and other loan acquisitions; strategic acquisitions; and capital management initiatives, including stock repurchases, debt repurchases, and dividend distributions.
The Board of Directors has authorized a stock repurchase program to repurchase up to a total of five million shares of the Company's Class A common stock during the three-year period ending May 8, 2028. As of December 31, 2025, 4,488,349 shares remained authorized for repurchase under the Company's stock repurchase program. The Company paid quarterly cash dividends totaling $1.19 per share in 2025 and $1.12 per share in 2024. The Company's Board of Directors has declared a first quarter 2026 cash dividend of $0.33 per share.
The Company faces prepayment risk on its FFELP loan portfolio, as the Higher Education Act allows borrowers to prepay FFEL Program loans at any time without penalty. Beginning in late 2021, the Company experienced accelerated run-off of its FFELP loan portfolio as borrowers consolidated into the Federal Direct Loan Program, though the Company has experienced a significant decrease in FFELP borrowers consolidating their loans into the Federal Direct Loan Program since August 2024. The One Big Beautiful Bill placed caps on federal lending for graduate students and parents of undergraduates, which could reduce future volumes of federal student loan borrowers while potentially expanding the market for private student lending. The Bill also significantly reduces tax incentives for clean energy, accelerating the expiration and phasing out of certain clean energy credits, which will impact the Company's ability to continue to invest in solar projects beyond the phase out periods.
The Company's largest fee-based customer, the Department of Education, represented 21% of revenue in 2025. Under the USDS contract, revenue earned on a per borrower blended basis has decreased compared to the legacy contract. The amount of future allocations of new loan volume could be negatively impacted if the Company is unable to consistently surpass comparable competitor and/or other performance metrics. The Company is also subject to risks related to the ability of Nelnet Bank to achieve its business objectives and effectively deploy loan and deposit strategies, and risks related to the Company's solar tax equity partnerships, including risks of not being able to realize tax credits which remain subject to recapture by taxing authorities.
Risk Factors
The Company's largest fee-based customer, the Department of Education, represented 21% of revenue in 2025, and the loss of this contract or a reduction in servicing volume could significantly lower servicing revenue. As of December 31, 2025, Nelnet Servicing was servicing $434.5 billion of government owned student loans for 11.4 million borrowers. The Company's FFELP loan portfolio will continue to decline over time as new originations were discontinued in 2010, and as of December 31, 2025, the amount of goodwill allocated to the FFELP portfolio reporting unit was $41.9 million. The Company's private education and consumer loan portfolios are unsecured and expose the Company to the full risk of loss in the event of borrower default, and the Company is actively expanding these portfolios. The Company's solar tax equity partnerships are subject to risks from changes in tax laws, including the One Big Beautiful Bill which accelerates the expiration and phasing out of clean energy credits. The Company's Executive Chairman beneficially owns 78.6% of the voting rights of shareholders and effectively has control over all matters.
Management Priorities
Management's discussion emphasizes the Company's transformation from a traditional student loan originator and servicer into a diversified operating holding company with primary businesses in consumer lending, loan servicing, payments, and technology-enabled services. Key themes include the continued decline of the FFELP loan portfolio and the Company's strategic focus on expanding private education, consumer, and other loan portfolios, as well as fee-based businesses. Management highlights the significant impact of the partial redemption of ALLO membership interests, which generated $410.9 million in cash proceeds and a pre-tax gain of $175.0 million. The Company also recognized $32.9 million of non-recurring revenue from a government servicing contract modification. Management notes the sale of NRE in November 2025 due to low margins and adverse market conditions. The Company expects its 2026 effective tax rate will range between 22.5% and 24.5%. Management emphasizes the importance of non-GAAP net income excluding derivative market value adjustments, which was $435.4 million in 2025, as a key performance metric.
View Source Annual Report on SEC.gov ↗
References
- [1] Item 1, Business — Overview
- [2] Item 1, Business — Loan Servicing and Systems
- [3] Item 7, MD&A — Consolidated Results of Operations
- [4] Item 7, MD&A — Loan Servicing and Systems Operating Segment
- [5] Item 7, MD&A — Loan Servicing and Systems Operating Segment
- [6] Item 7, MD&A — Loan Servicing and Systems Operating Segment
- [7] Item 7, MD&A — Education Technology Services and Payments Operating Segment
- [8] Item 7, MD&A — Education Technology Services and Payments Operating Segment
- [9] Item 7, MD&A — Education Technology Services and Payments Operating Segment
- [10] Item 7, MD&A — Education Technology Services and Payments Operating Segment
- [11] Item 7, MD&A — Education Technology Services and Payments Operating Segment
- [12] Item 7, MD&A — Asset Generation and Management Operating Segment
- [13] Item 7, MD&A — Asset Generation and Management Operating Segment
- [14] Item 7, MD&A — Nelnet Bank Operating Segment
- [15] Item 7, MD&A — Nelnet Bank Operating Segment
- [16] Item 7, MD&A — Nelnet Bank Operating Segment
- [17] Item 7, MD&A — NFS Other Operating Segments
- [18] Item 7, MD&A — NFS Other Operating Segments
- [19] Item 7, MD&A — NFS Other Operating Segments
- [20] Item 7, MD&A — Corporate and Other Activities
- [21] Item 7, MD&A — Corporate and Other Activities
- [22] Item 7, MD&A — Corporate and Other Activities
- [23] Item 7, MD&A — Corporate and Other Activities
- [24] Item 7, MD&A — Corporate and Other Activities
- [25] Item 7, MD&A — Corporate and Other Activities
- [26] Item 7, MD&A — Corporate and Other Activities
- [27] Item 7, MD&A — Corporate and Other Activities
- [28] Item 7, MD&A — Corporate and Other Activities
- [29] Item 7, MD&A — Corporate and Other Activities
- [30] Item 7, MD&A — Corporate and Other Activities
- [31] Item 7, MD&A — Corporate and Other Activities
- [32] Item 7, MD&A — Corporate and Other Activities
- [33] Item 7, MD&A — Corporate and Other Activities
- [34] Item 7, MD&A — Corporate and Other Activities
- [35] Item 7, MD&A — Corporate and Other Activities
- [36] Item 7, MD&A — Corporate and Other Activities
- [37] Item 7, MD&A — Corporate and Other Activities
- [38] Item 7, MD&A — Corporate and Other Activities
- [39] Item 7, MD&A — Corporate and Other Activities
- [40] Item 7, MD&A — Corporate and Other Activities
- [41] Item 7, MD&A — Corporate and Other Activities
- [42] Item 7, MD&A — Corporate and Other Activities
- [43] Item 7, MD&A — Corporate and Other Activities
- [44] Item 7, MD&A — Corporate and Other Activities
- [45] Item 7, MD&A — Corporate and Other Activities
- [46] Item 7, MD&A — Corporate and Other Activities
- [47] Item 7, MD&A — Corporate and Other Activities
- [48] Item 7, MD&A — Corporate and Other Activities
- [49] Item 7, MD&A — Corporate and Other Activities
- [50] Item 7, MD&A — Corporate and Other Activities
- [51] Item 7, MD&A — Corporate and Other Activities
- [52] Item 7, MD&A — Corporate and Other Activities
- [53] Item 7, MD&A — Corporate and Other Activities
- [54] Item 7, MD&A — Corporate and Other Activities
- [55] Item 7, MD&A — Corporate and Other Activities
- [56] Item 7, MD&A — Corporate and Other Activities
- [57] Item 7, MD&A — Corporate and Other Activities
- [58] Item 7, MD&A — Corporate and Other Activities
- [59] Item 7, MD&A — Corporate and Other Activities
- [60] Item 7, MD&A — Corporate and Other Activities
- [61] Item 7, MD&A — Corporate and Other Activities
- [62] Item 7, MD&A — Corporate and Other Activities
- [63] Item 7, MD&A — Corporate and Other Activities
- [64] Item 7, MD&A — Corporate and Other Activities
- [65] Item 7, MD&A — Corporate and Other Activities
- [66] Item 7, MD&A — Corporate and Other Activities
- [67] Item 7, MD&A — Corporate and Other Activities
- [68] Item 7, MD&A — Corporate and Other Activities
- [69] Item 7, MD&A — Corporate and Other Activities
- [70] Item 7, MD&A — Corporate and Other Activities
- [71] Item 7, MD&A — Corporate and Other Activities
- [72] Item 7, MD&A — Corporate and Other Activities
- [73] Item 7, MD&A — Corporate and Other Activities
- [74] Item 7, MD&A — Corporate and Other Activities
- [75] Item 7, MD&A — Corporate and Other Activities
- [76] Item 7, MD&A — Corporate and Other Activities
- [77] Item 7, MD&A — Corporate and Other Activities
- [78] Item 7, MD&A — Corporate and Other Activities
- [79] Item 7, MD&A — Corporate and Other Activities
- [80] Item 7, MD&A — Corporate and Other Activities
- [81] Item 7, MD&A — Corporate and Other Activities
- [82] Item 7, MD&A — Corporate and Other Activities
- [83] Item 7, MD&A — Corporate and Other Activities
- [84] Item 7, MD&A — Corporate and Other Activities
- [85] Item 7, MD&A — Corporate and Other Activities
- [86] Item 7, MD&A — Corporate and Other Activities
- [87] Item 7, MD&A — Corporate and Other Activities
- [88] Item 7, MD&A — Corporate and Other Activities
- [89] Item 7, MD&A — Corporate and Other Activities
- [90] Item 7, MD&A — Corporate and Other Activities
- [91] Item 7, MD&A — Corporate and Other Activities
- [92] Item 7, MD&A — Corporate and Other Activities
- [93] Item 7, MD&A — Corporate and Other Activities
- [94] Item 7, MD&A — Corporate and Other Activities
- [95] Item 7, MD&A — Corporate and Other Activities
- [96] Item 7, MD&A — Corporate and Other Activities
- [97] Item 7, MD&A — Corporate and Other Activities
- [98] Item 7, MD&A — Corporate and Other Activities
- [99] Item 7, MD&A — Corporate and Other Activities
- [100] Item 7, MD&A — Corporate and Other Activities
- [101] Item 7, MD&A — Corporate and Other Activities
- [102] Item 7, MD&A — Corporate and Other Activities
- [103] Item 7, MD&A — Corporate and Other Activities
- [104] Item 7, MD&A — Corporate and Other Activities
- [105] Item 7, MD&A — Corporate and Other Activities
- [106] Item 7, MD&A — Corporate and Other Activities
- [107] Item 7, MD&A — Corporate and Other Activities
- [108] Item 7, MD&A — Corporate and Other Activities
- [109] Item 7, MD&A — Corporate and Other Activities
- [110] Item 7, MD&A — Corporate and Other Activities
- [111] Item 7, MD&A — Corporate and Other Activities
- [112] Item 7, MD&A — Corporate and Other Activities
- [113] Item 7, MD&A — Corporate and Other Activities
- [114] Item 7, MD&A — Corporate and Other Activities
- [115] Item 7, MD&A — Corporate and Other Activities
- [116] Item 7, MD&A — Corporate and Other Activities
- [117] Item 7, MD&A — Corporate and Other Activities
- [118] Item 7, MD&A — Corporate and Other Activities
- [119] Item 7, MD&A — Corporate and Other Activities
- [120] Item 7, MD&A — Corporate and Other Activities
- [121] Item 7, MD&A — Corporate and Other Activities
- [122] Item 7, MD&A — Corporate and Other Activities
- [123] Item 7, MD&A — Corporate and Other Activities
- [124] Item 7, MD&A — Corporate and Other Activities
- [125] Item 7, MD&A — Corporate and Other Activities
- [126] Item 7, MD&A — Corporate and Other Activities
- [127] Item 7, MD&A — Corporate and Other Activities
- [128] Item 7, MD&A — Corporate and Other Activities
- [129] Item 7, MD&A — Corporate and Other Activities
- [130] Item 7, MD&A — Corporate and Other Activities
- [131] Item 7, MD&A — Corporate and Other Activities
- [132] Item 7, MD&A — Corporate and Other Activities
- [133] Item 7, MD&A — Corporate and Other Activities
- [134] Item 7, MD&A — Corporate and Other Activities
- [135] Item 7, MD&A — Corporate and Other Activities
- [136] Item 7, MD&A — Corporate and Other Activities
- [137] Item 7, MD&A — Corporate and Other Activities
- [138] Item 7, MD&A — Corporate and Other Activities
- [139] Item 7, MD&A — Corporate and Other Activities
- [140] Item 7, MD&A — Corporate and Other Activities
- [141] Item 7, MD&A — Corporate and Other Activities
- [142] Item 7, MD&A — Corporate and Other Activities
- [143] Item 7, MD&A — Corporate and Other Activities
- [144] Item 7, MD&A — Corporate and Other Activities
- [145] Item 7, MD&A — Corporate and Other Activities
- [146] Item 7, MD&A — Corporate and Other Activities
- [147] Item 7, MD&A — Corporate and Other Activities
- [148] Item 7, MD&A — Corporate and Other Activities
- [149] Item 7, MD&A — Corporate and Other Activities
- [150] Item 7, MD&A — Corporate and Other Activities
- [151] Item 7, MD&A — Corporate and Other Activities
- [152] Item 7, MD&A — Corporate and Other Activities
- [153] Item 7, MD&A — Corporate and Other Activities
- [154] Item 7, MD&A — Corporate and Other Activities
- [155] Item 7, MD&A — Corporate and Other Activities
- [156] Item 7, MD&A — Corporate and Other Activities
- [157] Item 7, MD&A — Corporate and Other Activities
- [158] Item 7, MD&A — Corporate and Other Activities
- [159] Item 7, MD&A — Corporate and Other Activities
- [160] Item 7, MD&A — Corporate and Other Activities
- [161] Item 7, MD&A — Corporate and Other Activities
- [162] Item 7, MD&A — Corporate and Other Activities
- [163] Item 7, MD&A — Corporate and Other Activities
- [164] Item 7, MD&A — Corporate and Other Activities
- [165] Item 7, MD&A — Corporate and Other Activities
- [166] Item 7, MD&A — Corporate and Other Activities
- [167] Item 7, MD&A — Corporate and Other Activities
- [168] Item 7, MD&A — Corporate and Other Activities
- [169] Item 7, MD&A — Corporate and Other Activities
- [170] Item 7, MD&A — Corporate and Other Activities
- [171] Item 7, MD&A — Corporate and Other Activities
- [172] Item 7, MD&A — Corporate and Other Activities
- [173] Item 7, MD&A — Corporate and Other Activities
- [174] Item 7, MD&A — Corporate and Other Activities
- [175] Item 7, MD&A — Corporate and Other Activities
- [176] Item 7, MD&A — Corporate and Other Activities
- [177] Item 7, MD&A — Corporate and Other Activities
- [178] Item 7, MD&A — Corporate and Other Activities
- [179] Item 7, MD&A — Corporate and Other Activities
- [180] Item 7, MD&A — Corporate and Other Activities
- [181] Item 7, MD&A — Corporate and Other Activities
- [182] Item 7, MD&A — Corporate and Other Activities
- [183] Item 7, MD&A — Corporate and Other Activities
- [184] Item 7, MD&A — Corporate and Other Activities
- [185] Item 7, MD&A — Corporate and Other Activities
- [186] Item 7, MD&A — Corporate and Other Activities
- [187] Item 7, MD&A — Corporate and Other Activities
- [188] Item 7, MD&A — Corporate and Other Activities
- [189] Item 7, MD&A — Corporate and Other Activities
- [190] Item 7, MD&A — Corporate and Other Activities
- [191] Item 7, MD&A — Corporate and Other Activities
- [192] Item 7, MD&A — Corporate and Other Activities
- [193] Item 7, MD&A — Corporate and Other Activities
- [194] Item 7, MD&A — Corporate and Other Activities
- [195] Item 7, MD&A — Corporate and Other Activities
- [196] Item 7, MD&A — Corporate and Other Activities
- [197] Item 7, MD&A — Corporate and Other Activities
- [198] Item 7, MD&A — Corporate and Other Activities
- [199] Item 7, MD&A — Corporate and Other Activities
- [200] Item 7, MD&A — Corporate and Other Activities
- [201] Item 7, MD&A — Corporate and Other Activities
- [202] Item 7, MD&A — Corporate and Other Activities
- [203] Item 7, MD&A — Corporate and Other Activities
- [204] Item 7, MD&A — Corporate and Other Activities
- [205] Item 7, MD&A — Corporate and Other Activities
- [206] Item 7, MD&A — Corporate and Other Activities
- [207] Item 7, MD&A — Corporate and Other Activities
- [208] Item 7, MD&A — Corporate and Other Activities
- [209] Item 7, MD&A — Corporate and Other Activities
- [210] Item 7, MD&A — Corporate and Other Activities
- [211] Item 7, MD&A — Corporate and Other Activities
- [212] Item 7, MD&A — Corporate and Other Activities
- [213] Item 7, MD&A — Corporate and Other Activities
- [214] Item 7, MD&A — Corporate and Other Activities
- [215] Item 7, MD&A — Corporate and Other Activities
- [216] Item 7, MD&A — Corporate and Other Activities
- [217] Item 7, MD&A — Corporate and Other Activities
- [218] Item 7, MD&A — Corporate and Other Activities
- [219] Item 7, MD&A — Corporate and Other Activities
- [220] Item 7, MD&A — Corporate and Other Activities
- [221] Item 7, MD&A — Corporate and Other Activities
- [222] Item 7, MD&A — Corporate and Other Activities
- [223] Item 7, MD&A — Corporate and Other Activities
- [224] Item 7, MD&A — Corporate and Other Activities
- [225] Item 7, MD&A — Corporate and Other Activities
- [226] Item 7, MD&A — Corporate and Other Activities
- [227] Item 7, MD&A — Corporate and Other Activities
- [228] Item 7, MD&A — Corporate and Other Activities
- [229] Item 7, MD&A — Corporate and Other Activities
- [230] Item 7, MD&A — Corporate and Other Activities
- [231] Item 7, MD&A — Corporate and Other Activities
- [232] Item 7, MD&A — Corporate and Other Activities
- [233] Item 7, MD&A — Corporate and Other Activities
- [234] Item 7, MD&A — Corporate and Other Activities
- [235] Item 7, MD&A — Corporate and Other Activities
- [236] Item 7, MD&A — Corporate and Other Activities
- [237] Item 7, MD&A — Corporate and Other Activities
- [238] Item 7, MD&A — Corporate and Other Activities
- [239] Item 7, MD&A — Corporate and Other Activities
- [240] Item 7, MD&A — Corporate and Other Activities
- [241] Item 7, MD&A — Corporate and Other Activities
- [242] Item 7, MD&A — Corporate and Other Activities
- [243] Item 7, MD&A — Corporate and Other Activities
- [244] Item 7, MD&A — Corporate and Other Activities
- [245] Item 7, MD&A — Corporate and Other Activities
- [246] Item 7, MD&A — Corporate and Other Activities
- [247] Item 7, MD&A — Corporate and Other Activities
- [248] Item 7, MD&A — Corporate and Other Activities
- [249] Item 7, MD&A — Corporate and Other Activities
- [250] Item 7, MD&A — Corporate and Other Activities
- [251] Item 7, MD&A — Corporate and Other Activities
- [252] Item 7, MD&A — Corporate and Other Activities
- [253] Item 7, MD&A — Corporate and Other Activities
- [254] Item 7, MD&A — Corporate and Other Activities
- [255] Item 7, MD&A — Corporate and Other Activities
- [256] Item 7, MD&A — Corporate and Other Activities
- [257] Item 7, MD&A — Corporate and Other Activities
- [258] Item 7, MD&A — Corporate and Other Activities
- [259] Item 7, MD&A — Corporate and Other Activities
- [260] Item 7, MD&A — Corporate and Other Activities
- [261] Item 7, MD&A — Corporate and Other Activities
- [262] Item 7, MD&A — Corporate and Other Activities
- [263] Item 7, MD&A — Corporate and Other Activities
- [264] Item 7, MD&A — Corporate and Other Activities
- [265] Item 7, MD&A — Corporate and Other Activities
- [266] Item 7, MD&A — Corporate and Other Activities
- [267] Item 7, MD&A — Corporate and Other Activities
- [268] Item 7, MD&A — Corporate and Other Activities
- [269] Item 7, MD&A — Corporate and Other Activities
- [270] Item 7, MD&A — Corporate and Other Activities
- [271] Item 7, MD&A — Corporate and Other Activities
- [272] Item 7, MD&A — Corporate and Other Activities
- [273] Item 7, MD&A — Corporate and Other Activities
- [274] Item 7, MD&A — Corporate and Other Activities
- [275] Item 7, MD&A — Corporate and Other Activities
- [276] Item 7, MD&A — Corporate and Other Activities
- [277] Item 7, MD&A — Corporate and Other Activities
- [278] Item 7, MD&A — Corporate and Other Activities
- [279] Item 7, MD&A — Corporate and Other Activities
- [280] Item 7, MD&A — Corporate and Other Activities
- [281] Item 7, MD&A — Corporate and Other Activities
- [282] Item 7, MD&A — Corporate and Other Activities
- [283] Item 7, MD&A — Corporate and Other Activities
- [284] Item 7, MD&A — Corporate and Other Activities
- [285] Item 7, MD&A — Corporate and Other Activities
- [286] Item 7, MD&A — Corporate and Other Activities
- [287] Item 7, MD&A — Corporate and Other Activities
- [288] Item 7, MD&A — Corporate and Other Activities
- [289] Item 7, MD&A — Corporate and Other Activities
- [290] Item 7, MD&A — Corporate and Other Activities
- [291] Item 7, MD&A — Corporate and Other Activities
- [292] Item 7, MD&A — Corporate and Other Activities
- [293] Item 7, MD&A — Corporate and Other Activities
- [294] Item 7, MD&A — Corporate and Other Activities
- [295] Item 7, MD&A — Corporate and Other Activities
- [296] Item 7, MD&A — Corporate and Other Activities
- [297] Item 7, MD&A — Corporate and Other Activities
- [298] Item 7, MD&A — Corporate and Other Activities
- [299] Item 7, MD&A — Corporate and Other Activities
- [300] Item 7, MD&A — Corporate and Other Activities
- [301] Item 7, MD&A — Corporate and Other Activities
- [302] Item 7, MD&A — Corporate and Other Activities
- [303] Item 7, MD&A — Corporate and Other Activities
- [304] Item 7, MD&A — Corporate and Other Activities
- [305] Item 7, MD&A — Corporate and Other Activities
- [306] Item 7, MD&A — Corporate and Other Activities
- [307] Item 7, MD&A — Corporate and Other Activities
- [308] Item 7, MD&A — Corporate and Other Activities
- [309] Item 7, MD&A — Corporate and Other Activities
- [310] Item 7, MD&A — Corporate and Other Activities
- [311] Item 7, MD&A — Corporate and Other Activities
- [312] Item 7, MD&A — Corporate and Other Activities
- [313] Item 7, MD&A — Corporate and Other Activities
- [314] Item 7, MD&A — Corporate and Other Activities
- [315] Item 7, MD&A — Corporate and Other Activities
- [316] Item 7, MD&A — Corporate and Other Activities
- [317] Item 7, MD&A — Corporate and Other Activities
- [318] Item 7, MD&A — Corporate and Other Activities
- [319] Item 7, MD&A — Corporate and Other Activities
- [320] Item 7, MD&A — Corporate and Other Activities
- [321] Item 7, MD&A — Corporate and Other Activities
- [322] Item 7, MD&A — Corporate and Other Activities
- [323] Item 7, MD&A — Corporate and Other Activities
- [324] Item 7, MD&A — Corporate and Other Activities
- [325] Item 7, MD&A — Corporate and Other Activities
- [326] Item 7, MD&A — Corporate and Other Activities
- [327] Item 7, MD&A — Corporate and Other Activities
- [328] Item 7, MD&A — Corporate and Other Activities
- [329] Item 7, MD&A — Corporate and Other Activities
- [330] Item 7, MD&A — Corporate and Other Activities
- [331] Item 7, MD&A — Corporate and Other Activities
- [332] Item 7, MD&A — Corporate and Other Activities
- [333] Item 7, MD&A — Corporate and Other Activities
- [334] Item 7, MD&A — Corporate and Other Activities
- [335] Item 7, MD&A — Corporate and Other Activities
- [336] Item 7, MD&A — Corporate and Other Activities
- [337] Item 7, MD&A — Corporate and Other Activities
- [338] Item 7, MD&A — Corporate and Other Activities
- [339] Item 7, MD&A — Corporate and Other Activities
- [340] Item 7, MD&A — Corporate and Other Activities
- [341] Item 7, MD&A — Corporate and Other Activities
- [342] Item 7, MD&A — Corporate and Other Activities
- [343] Item 7, MD&A — Corporate and Other Activities
- [344] Item 7, MD&A — Corporate and Other Activities
- [345] Item 7, MD&A — Corporate and Other Activities
- [346] Item 7, MD&A — Corporate and Other Activities
- [347] Item 7, MD&A — Corporate and Other Activities
- [348] Item 7, MD&A — Corporate and Other Activities
- [349] Item 7, MD&A — Corporate and Other Activities
- [350] Item 7, MD&A — Corporate and Other Activities
- [351] Item 7, MD&A — Corporate and Other Activities
- [352] Item 7, MD&A — Corporate and Other Activities
- [353] Item 7, MD&A — Corporate and Other Activities
- [354] Item 7, MD&A — Corporate and Other Activities
- [355] Item 7, MD&A — Corporate and Other Activities
- [356] Item 7, MD&A — Corporate and Other Activities
- [357] Item 7, MD&A — Corporate and Other Activities
- [358] Item 7, MD&A — Corporate and Other Activities
- [359] Item 7, MD&A — Corporate and Other Activities
- [360] Item 7, MD&A — Corporate and Other Activities
- [361] Item 7, MD&A — Corporate and Other Activities
- [362] Item 7, MD&A — Corporate and Other Activities
- [363] Item 7, MD&A — Corporate and Other Activities
- [364] Item 7, MD&A — Corporate and Other Activities
- [365] Item 7, MD&A — Corporate and Other Activities
- [366] Item 7, MD&A — Corporate and Other Activities
- [367] Item 7, MD&A — Corporate and Other Activities
- [368] Item 7, MD&A — Corporate and Other Activities
- [369] Item 7, MD&A — Corporate and Other Activities
- [370] Item 7, MD&A — Corporate and Other Activities
- [371] Item 7, MD&A — Corporate and Other Activities
- [372] Item 7, MD&A — Corporate and Other Activities
- [373] Item 7, MD&A — Corporate and Other Activities
- [374] Item 7, MD&A — Corporate and Other Activities
- [375] Item 7, MD&A — Corporate and Other Activities
- [376] Item 7, MD&A — Corporate and Other Activities
- [377] Item 7, MD&A — Corporate and Other Activities
- [378] Item 7, MD&A — Corporate and Other Activities
- [379] Item 7, MD&A — Corporate and Other Activities
- [380] Item 7, MD&A — Corporate and Other Activities
- [381] Item 7, MD&A — Corporate and Other Activities
- [382] Item 7, MD&A — Corporate and Other Activities
- [383] Item 7, MD&A — Corporate and Other Activities
- [384] Item 7, MD&A — Corporate and Other Activities
- [385] Item 7, MD&A — Corporate and Other Activities
- [386] Item 7, MD&A — Corporate and Other Activities
- [387] Item 7, MD&A — Corporate and Other Activities
- [388] Item 7, MD&A — Corporate and Other Activities
- [389] Item 7, MD&A — Corporate and Other Activities
- [390] Item 7, MD&A — Corporate and Other Activities
- [391] Item 7, MD&A — Corporate and Other Activities
- [392] Item 7, MD&A — Corporate and Other Activities
- [393] Item 7, MD&A — Corporate and Other Activities
- [394] Item 7, MD&A — Corporate and Other Activities
- [395] Item 7, MD&A — Corporate and Other Activities
- [396] Item 7, MD&A — Corporate and Other Activities
- [397] Item 7, MD&A — Corporate and Other Activities
- [398] Item 7, MD&A — Corporate and Other Activities
- [399] Item 7, MD&A — Corporate and Other Activities
- [400] Item 7, MD&A — Corporate and Other Activities
- [401] Item 7, MD&A — Corporate and Other Activities
- [402] Item 7, MD&A — Corporate and Other Activities
- [403] Item 7, MD&A — Corporate and Other Activities
- [404] Item 7, MD&A — Corporate and Other Activities
- [405] Item 7, MD&A — Corporate and Other Activities
- [406] Item 7, MD&A — Corporate and Other Activities
- [407] Item 7, MD&A — Corporate and Other Activities
- [408] Item 7, MD&A — Corporate and Other Activities
- [409] Item 7, MD&A — Corporate and Other Activities
- [410] Item 7, MD&A — Corporate and Other Activities
- [411] Item 7, MD&A — Corporate and Other Activities
- [412] Item 7, MD&A — Corporate and Other Activities
- [413] Item 7, MD&A — Corporate and Other Activities
- [414] Item 7, MD&A — Corporate and Other Activities
- [415] Item 7, MD&A — Corporate and Other Activities
- [416] Item 7, MD&A — Corporate and Other Activities
- [417] Item 7, MD&A — Corporate and Other Activities
- [418] Item 7, MD&A — Corporate and Other Activities
- [419] Item 7, MD&A — Corporate and Other Activities
- [420] Item 7, MD&A — Corporate and Other Activities
- [421] Item 7, MD&A — Corporate and Other Activities
- [422] Item 7, MD&A — Corporate and Other Activities
- [423] Item 7, MD&A — Corporate and Other Activities
- [424] Item 7, MD&A — Corporate and Other Activities
- [425] Item 7, MD&A — Corporate and Other Activities
- [426] Item 7, MD&A — Corporate and Other Activities
- [427] Item 7, MD&A — Corporate and Other Activities
- [428] Item 7, MD&A — Corporate and Other Activities
- [429] Item 7, MD&A — Corporate and Other Activities
- [430] Item 7, MD&A — Corporate and Other Activities
- [431] Item 7, MD&A — Corporate and Other Activities
- [432] Item 7, MD&A — Corporate and Other Activities
- [433] Item 7, MD&A — Corporate and Other Activities
- [434] Item 7, MD&A — Corporate and Other Activities
- [435] Item 7, MD&A — Corporate and Other Activities
- [436] Item 7, MD&A — Corporate and Other Activities
- [437] Item 7, MD&A — Corporate and Other Activities
- [438] Item 7, MD&A — Corporate and Other Activities
- [439] Item 7, MD&A — Corporate and Other Activities
- [440] Item 7, MD&A — Corporate and Other Activities
- [441] Item 7, MD&A — Corporate and Other Activities
- [442] Item 7, MD&A — Corporate and Other Activities
- [443] Item 7, MD&A — Corporate and Other Activities
- [444] Item 7, MD&A — Corporate and Other Activities
- [445] Item 7, MD&A — Corporate and Other Activities
- [446] Item 7, MD&A — Corporate and Other Activities
- [447] Item 7, MD&A — Corporate and Other Activities
- [448] Item 7, MD&A — Corporate and Other Activities
- [449] Item 7, MD&A — Corporate and Other Activities
- [450] Item 7, MD&A — Corporate and Other Activities
- [451] Item 7, MD&A — Corporate and Other Activities
- [452] Item 7, MD&A — Corporate and Other Activities
- [453] Item 7, MD&A — Corporate and Other Activities
- [454] Item 7, MD&A — Corporate and Other Activities
- [455] Item 7, MD&A — Corporate and Other Activities
- [456] Item 7, MD&A — Corporate and Other Activities
- [457] Item 7, MD&A — Corporate and Other Activities
- [458] Item 7, MD&A — Corporate and Other Activities
- [459] Item 7, MD&A — Corporate and Other Activities
- [460] Item 7, MD&A — Corporate and Other Activities
- [461] Item 7, MD&A — Corporate and Other Activities
- [462] Item 7, MD&A — Corporate and Other Activities
- [463] Item 7, MD&A — Corporate and Other Activities
- [464] Item 7, MD&A — Corporate and Other Activities
- [465] Item 7, MD&A — Corporate and Other Activities
- [466] Item 7, MD&A — Corporate and Other Activities
- [467] Item 7, MD&A — Corporate and Other Activities
- [468] Item 7, MD&A — Corporate and Other Activities
- [469] Item 7, MD&A — Corporate and Other Activities
- [470] Item 7, MD&A — Corporate and Other Activities
- [471] Item 7, MD&A — Corporate and Other Activities
- [472] Item 7, MD&A — Corporate and Other Activities
- [473] Item 7, MD&A — Corporate and Other Activities
- [474] Item 7, MD&A — Corporate and Other Activities
- [475] Item 7, MD&A — Corporate and Other Activities
- [476] Item 7, MD&A — Corporate and Other Activities
- [477] Item 7, MD&A — Corporate and Other Activities
- [478] Item 7, MD&A — Corporate and Other Activities
- [479] Item 7, MD&A — Corporate and Other Activities
- [480] Item 7, MD&A — Corporate and Other Activities
- [481] Item 7, MD&A — Corporate and Other Activities
- [482] Item 7, MD&A — Corporate and Other Activities
- [483] Item 7, MD&A — Corporate and Other Activities
- [484] Item 7, MD&A — Corporate and Other Activities
- [485] Item 7, MD&A — Corporate and Other Activities
- [486] Item 7, MD&A — Corporate and Other Activities
- [487] Item 7, MD&A — Corporate and Other Activities
- [488] Item 7, MD&A — Corporate and Other Activities
- [489] Item 7, MD&A — Corporate and Other Activities
- [490] Item 7, MD&A — Corporate and Other Activities
- [491] Item 7, MD&A — Corporate and Other Activities
- [492] Item 7, MD&A — Corporate and Other Activities
- [493] Item 7, MD&A — Corporate and Other Activities
- [494] Item 7, MD&A — Corporate and Other Activities
- [495] Item 7, MD&A — Corporate and Other Activities
- [496] Item 7, MD&A — Corporate and Other Activities
- [497] Item 7, MD&A — Corporate and Other Activities
- [498] Item 7, MD&A — Corporate and Other Activities
- [499] Item 7, MD&A — Corporate and Other Activities
- [500] Item 7, MD&A — Corporate and Other Activities
- [501] Item 7, MD&A — Corporate and Other Activities
- [502] Item 7, MD&A — Corporate and Other Activities
- [503] Item 7, MD&A — Corporate and Other Activities
- [504] Item 7, MD&A — Corporate and Other Activities
- [505] Item 7, MD&A — Corporate and Other Activities
- [506] Item 7, MD&A — Corporate and Other Activities
- [507] Item 7, MD&A — Corporate and Other Activities
- [508] Item 7, MD&A — Corporate and Other Activities
- [509] Item 7, MD&A — Corporate and Other Activities
- [510] Item 7, MD&A — Corporate and Other Activities
- [511] Item 7, MD&A — Corporate and Other Activities
- [512] Item 7, MD&A — Corporate and Other Activities
- [513] Item 7, MD&A — Corporate and Other Activities
- [514] Item 7, MD&A — Corporate and Other Activities
- [515] Item 7, MD&A — Corporate and Other Activities
- [516] Item 7, MD&A — Corporate and Other Activities
- [517] Item 7, MD&A — Corporate and Other Activities
- [518] Item 7, MD&A — Corporate and Other Activities
- [519] Item 7, MD&A — Corporate and Other Activities
- [520] Item 7, MD&A — Corporate and Other Activities
- [521] Item 7, MD&A — Corporate and Other Activities
- [522] Item 7, MD&A — Corporate and Other Activities
- [523] Item 7, MD&A — Corporate and Other Activities
- [524] Item 7, MD&A — Corporate and Other Activities
- [525] Item 7, MD&A — Corporate and Other Activities
- [526] Item 7, MD&A — Corporate and Other Activities
- [527] Item 7, MD&A — Corporate and Other Activities
- [528] Item 7, MD&A — Corporate and Other Activities
- [529] Item 7, MD&A — Corporate and Other Activities
- [530] Item 7, MD&A — Corporate and Other Activities
- [531] Item 7, MD&A — Corporate and Other Activities
- [532] Item 7, MD&A — Corporate and Other Activities
- [533] Item 7, MD&A — Corporate and Other Activities
- [534] Item 7, MD&A — Corporate and Other Activities
- [535] Item 7, MD&A — Corporate and Other Activities
- [536] Item 7, MD&A — Corporate and Other Activities
- [537] Item 7, MD&A — Corporate and Other Activities
- [538] Item 7, MD&A — Corporate and Other Activities
- [539] Item 7, MD&A — Corporate and Other Activities
- [540] Item 7, MD&A — Corporate and Other Activities
- [541] Item 7, MD&A — Corporate and Other Activities
- [542] Item 7, MD&A — Corporate and Other Activities
- [543] Item 7, MD&A — Corporate and Other Activities
- [544] Item 7, MD&A — Corporate and Other Activities
- [545] Item 7, MD&A — Corporate and Other Activities
- [546] Item 7, MD&A — Corporate and Other Activities
- [547] Item 7, MD&A — Corporate and Other Activities
- [548] Item 7, MD&A — Corporate and Other Activities
- [549] Item 7, MD&A — Corporate and Other Activities
- [550] Item 7, MD&A — Corporate and Other Activities
- [551] Item 7, MD&A — Corporate and Other Activities
- [552] Item 7, MD&A — Corporate and Other Activities
- [553] Item 7, MD&A — Corporate and Other Activities
- [554] Item 7, MD&A — Corporate and Other Activities
- [555] Item 7, MD&A — Corporate and Other Activities
- [556] Item 7, MD&A — Corporate and Other Activities
- [557] Item 7, MD&A — Corporate and Other Activities
- [558] Item 7, MD&A — Corporate and Other Activities
- [559] Item 7, MD&A — Corporate and Other Activities
- [560] Item 7, MD&A — Corporate and Other Activities
- [561] Item 7, MD&A — Corporate and Other Activities
- [562] Item 7, MD&A — Corporate and Other Activities
- [563] Item 7, MD&A — Corporate and Other Activities
- [564] Item 7, MD&A — Corporate and Other Activities
- [565] Item 7, MD&A — Corporate and Other Activities
- [566] Item 7, MD&A — Corporate and Other Activities
- [567] Item 7, MD&A — Corporate and Other Activities
- [568] Item 7, MD&A — Corporate and Other Activities
- [569] Item 7, MD&A — Corporate and Other Activities
- [570] Item 7, MD&A — Corporate and Other Activities
- [571] Item 7, MD&A — Corporate and Other Activities
- [572] Item 7, MD&A — Corporate and Other Activities
- [573] Item 7, MD&A — Corporate and Other Activities
- [574] Item 7, MD&A — Corporate and Other Activities
- [575] Item 7, MD&A — Corporate and Other Activities
- [576] Item 7, MD&A — Corporate and Other Activities
- [577] Item 7, MD&A — Corporate and Other Activities
- [578] Item 7, MD&A — Corporate and Other Activities
- [579] Item 7, MD&A — Corporate and Other Activities
- [580] Item 7, MD&A — Corporate and Other Activities
- [581] Item 7, MD&A — Corporate and Other Activities
- [582] Item 7, MD&A — Corporate and Other Activities
- [583] Item 7, MD&A — Corporate and Other Activities
- [584] Item 7, MD&A — Corporate and Other Activities
- [585] Item 7, MD&A — Corporate and Other Activities
- [586] Item 7, MD&A — Corporate and Other Activities
- [587] Item 7, MD&A — Corporate and Other Activities
- [588] Item 7, MD&A — Corporate and Other Activities
- [589] Item 7, MD&A — Corporate and Other Activities
- [590] Item 7, MD&A — Corporate and Other Activities
- [591] Item 7, MD&A — Corporate and Other Activities
- [592] Item 7, MD&A — Corporate and Other Activities
- [593] Item 7, MD&A — Corporate and Other Activities
- [594] Item 7, MD&A — Corporate and Other Activities
- [595] Item 7, MD&A — Corporate and Other Activities
- [596] Item 7, MD&A — Corporate and Other Activities
- [597] Item 7, MD&A — Corporate and Other Activities
- [598] Item 7, MD&A — Corporate and Other Activities
- [599] Item 7, MD&A — Corporate and Other Activities
- [600] Item 7, MD&A — Corporate and Other Activities
- [601] Item 7, MD&A — Corporate and Other Activities
- [602] Item 7, MD&A — Corporate and Other Activities
- [603] Item 7, MD&A — Corporate and Other Activities
- [604] Item 7, MD&A — Corporate and Other Activities
- [605] Item 7, MD&A — Corporate and Other Activities
- [606] Item 7, MD&A — Corporate and Other Activities
- [607] Item 7, MD&A — Corporate and Other Activities
- [608] Item 7, MD&A — Corporate and Other Activities
- [609] Item 7, MD&A — Corporate and Other Activities
- [610] Item 7, MD&A — Corporate and Other Activities
- [611] Item 7, MD&A — Corporate and Other Activities
- [612] Item 7, MD&A — Corporate and Other Activities
- [613] Item 7, MD&A — Corporate and Other Activities
- [614] Item 7, MD&A — Corporate and Other Activities
- [615] Item 7, MD&A — Corporate and Other Activities
- [616] Item 7, MD&A — Corporate and Other Activities
- [617] Item 7, MD&A — Corporate and Other Activities
- [618] Item 7, MD&A — Corporate and Other Activities
- [619] Item 7, MD&A — Corporate and Other Activities
- [620] Item 7, MD&A — Corporate and Other Activities
- [621] Item 7, MD&A — Corporate and Other Activities
- [622] Item 7, MD&A — Corporate and Other Activities
- [623] Item 7, MD&A — Corporate and Other Activities
- [624] Item 7, MD&A — Corporate and Other Activities
- [625] Item 7, MD&A — Corporate and Other Activities
- [626] Item 7, MD&A — Corporate and Other Activities
- [627] Item 7, MD&A — Corporate and Other Activities
- [628] Item 7, MD&A — Corporate and Other Activities
- [629] Item 7, MD&A — Corporate and Other Activities
- [630] Item 7, MD&A — Corporate and Other Activities
- [631] Item 7, MD&A — Corporate and Other Activities
- [632] Item 7, MD&A — Corporate and Other Activities
- [633] Item 7, MD&A — Corporate and Other Activities
- [634] Item 7, MD&A — Corporate and Other Activities
- [635] Item 7, MD&A — Corporate and Other Activities
- [636] Item 7, MD&A — Corporate and Other Activities
- [637] Item 7, MD&A — Corporate and Other Activities
- [638] Item 7, MD&A — Corporate and Other Activities
- [639] Item 7, MD&A — Corporate and Other Activities
- [640] Item 7, MD&A — Corporate and Other Activities
- [641] Item 7, MD&A — Corporate and Other Activities
- [642] Item 7, MD&A — Corporate and Other Activities
- [643] Item 7, MD&A — Corporate and Other Activities
- [644] Item 7, MD&A — Corporate and Other Activities
- [645] Item 7, MD&A — Corporate and Other Activities
- [646] Item 7, MD&A — Corporate and Other Activities
- [647] Item 7, MD&A — Corporate and Other Activities
- [648] Item 7, MD&A — Corporate and Other Activities
- [649] Item 7, MD&A — Corporate and Other Activities
- [650] Item 7, MD&A — Corporate and Other Activities
- [651] Item 7, MD&A — Corporate and Other Activities
- [652] Item 7, MD&A — Corporate and Other Activities
- [653] Item 7, MD&A — Corporate and Other Activities
- [654] Item 7, MD&A — Corporate and Other Activities
- [655] Item 7, MD&A — Corporate and Other Activities
- [656] Item 7, MD&A — Corporate and Other Activities
- [657] Item 7, MD&A — Corporate and Other Activities
- [658] Item 7, MD&A — Corporate and Other Activities
- [659] Item 7, MD&A — Corporate and Other Activities
- [660] Item 7, MD&A — Corporate and Other Activities
- [661] Item 7, MD&A — Corporate and Other Activities
- [662] Item 7, MD&A — Corporate and Other Activities
- [663] Item 7, MD&A — Corporate and Other Activities
- [664] Item 7, MD&A — Corporate and Other Activities
- [665] Item 7, MD&A — Corporate and Other Activities
- [666] Item 7, MD&A — Corporate and Other Activities
- [667] Item 7, MD&A — Corporate and Other Activities
- [668] Item 7, MD&A — Corporate and Other Activities
- [669] Item 7, MD&A — Corporate and Other Activities
- [670] Item 7, MD&A — Corporate and Other Activities
- [671] Item 7, MD&A — Corporate and Other Activities
- [672] Item 7, MD&A — Corporate and Other Activities
- [673] Item 7, MD&A — Corporate and Other Activities
- [674] Item 7, MD&A — Corporate and Other Activities
- [675] Item 7, MD&A — Corporate and Other Activities
- [676] Item 7, MD&A — Corporate and Other Activities
- [677] Item 7, MD&A — Corporate and Other Activities
- [678] Item 7, MD&A — Corporate and Other Activities
- [679] Item 7, MD&A — Corporate and Other Activities
- [680] Item 7, MD&A — Corporate and Other Activities
- [681] Item 7, MD&A — Corporate and Other Activities
- [682] Item 7, MD&A — Corporate and Other Activities
- [683] Item 7, MD&A — Corporate and Other Activities
- [684] Item 7, MD&A — Corporate and Other Activities
- [685] Item 7, MD&A — Corporate and Other Activities
- [686] Item 7, MD&A — Corporate and Other Activities
- [687] Item 7, MD&A — Corporate and Other Activities
- [688] Item 7, MD&A — Corporate and Other Activities
- [689] Item 7, MD&A — Corporate and Other Activities
- [690] Item 7, MD&A — Corporate and Other Activities
- [691] Item 7, MD&A — Corporate and Other Activities
- [692] Item 7, MD&A — Corporate and Other Activities
- [693] Item 7, MD&A — Corporate and Other Activities
- [694] Item 7, MD&A — Corporate and Other Activities
- [695] Item 7, MD&A — Corporate and Other Activities
- [696] Item 7, MD&A — Corporate and Other Activities
- [697] Item 7, MD&A — Corporate and Other Activities
- [698] Item 7, MD&A — Corporate and Other Activities
- [699] Item 7, MD&A — Corporate and Other Activities
- [700] Item 7, MD&A — Corporate and Other Activities
- [701] Item 7, MD&A — Corporate and Other Activities
- [702] Item 7, MD&A — Corporate and Other Activities
- [703] Item 7, MD&A — Corporate and Other Activities
- [704] Item 7, MD&A — Corporate and Other Activities
- [705] Item 7, MD&A — Corporate and Other Activities
- [706] Item 7, MD&A — Corporate and Other Activities
- [707] Item 7, MD&A — Corporate and Other Activities
- [708] Item 7, MD&A — Corporate and Other Activities
- [709] Item 7, MD&A — Corporate and Other Activities
- [710] Item 7, MD&A — Corporate and Other Activities
- [711] Item 7, MD&A — Corporate and Other Activities
- [712] Item 7, MD&A — Corporate and Other Activities
- [713] Item 7, MD&A — Corporate and Other Activities
- [714] Item 7, MD&A — Corporate and Other Activities
- [715] Item 7, MD&A — Corporate and Other Activities
- [716] Item 7, MD&A — Corporate and Other Activities
- [717] Item 7, MD&A — Corporate and Other Activities
- [718] Item 7, MD&A — Corporate and Other Activities
- [719] Item 7, MD&A — Corporate and Other Activities
- [720] Item 7, MD&A — Corporate and Other Activities
- [721] Item 7, MD&A — Corporate and Other Activities
- [722] Item 7, MD&A — Corporate and Other Activities
- [723] Item 7, MD&A — Corporate and Other Activities
- [724] Item 7, MD&A — Corporate and Other Activities
- [725] Item 7, MD&A — Corporate and Other Activities
- [726] Item 7, MD&A — Corporate and Other Activities
- [727] Item 7, MD&A — Corporate and Other Activities
- [728] Item 7, MD&A — Corporate and Other Activities
- [729] Item 7, MD&A — Corporate and Other Activities
- [730] Item 7, MD&A — Corporate and Other Activities
- [731] Item 7, MD&A — Corporate and Other Activities
- [732] Item 7, MD&A — Corporate and Other Activities
- [733] Item 7, MD&A — Corporate and Other Activities
- [734] Item 7, MD&A — Corporate and Other Activities
- [735] Item 7, MD&A — Corporate and Other Activities
- [736] Item 7, MD&A — Corporate and Other Activities
- [737] Item 7, MD&A — Corporate and Other Activities
- [738] Item 7, MD&A — Corporate and Other Activities
- [739] Item 7, MD&A — Corporate and Other Activities
- [740] Item 7, MD&A — Corporate and Other Activities
- [741] Item 7, MD&A — Corporate and Other Activities
- [742] Item 7, MD&A — Corporate and Other Activities
- [743] Item 7, MD&A — Corporate and Other Activities
- [744] Item 7, MD&A — Corporate and Other Activities
- [745] Item 7, MD&A — Corporate and Other Activities
- [746] Item 7, MD&A — Corporate and Other Activities
- [747] Item 7, MD&A — Corporate and Other Activities
- [748] Item 7, MD&A — Corporate and Other Activities
- [749] Item 7, MD&A — Corporate and Other Activities
- [750] Item 7, MD&A — Corporate and Other Activities
- [751] Item 7, MD&A — Corporate and Other Activities
- [752] Item 7, MD&A — Corporate and Other Activities
- [753] Item 7, MD&A — Corporate and Other Activities
- [754] Item 7, MD&A — Corporate and Other Activities
- [755] Item 7, MD&A — Corporate and Other Activities
- [756] Item 7, MD&A — Corporate and Other Activities
- [757] Item 7, MD&A — Corporate and Other Activities
- [758] Item 7, MD&A — Corporate and Other Activities
- [759] Item 7, MD&A — Corporate and Other Activities
- [760] Item 7, MD&A — Corporate and Other Activities
- [761] Item 7, MD&A — Corporate and Other Activities
- [762] Item 7, MD&A — Corporate and Other Activities
- [763] Item 7, MD&A — Corporate and Other Activities
- [764] Item 7, MD&A — Corporate and Other Activities
- [765] Item 7, MD&A — Corporate and Other Activities
- [766] Item 7, MD&A — Corporate and Other Activities
- [767] Item 7, MD&A — Corporate and Other Activities
- [768] Item 7, MD&A — Corporate and Other Activities
- [769] Item 7, MD&A — Corporate and Other Activities
- [770] Item 7, MD&A — Corporate and Other Activities
- [771] Item 7, MD&A — Corporate and Other Activities
- [772] Item 7, MD&A — Corporate and Other Activities
- [773] Item 7, MD&A — Corporate and Other Activities
- [774] Item 7, MD&A — Corporate and Other Activities
- [775] Item 7, MD&A — Corporate and Other Activities
- [776] Item 7, MD&A — Corporate and Other Activities
- [777] Item 7, MD&A — Corporate and Other Activities
- [778] Item 7, MD&A — Corporate and Other Activities
- [779] Item 7, MD&A — Corporate and Other Activities
- [780] Item 7, MD&A — Corporate and Other Activities
- [781] Item 7, MD&A — Corporate and Other Activities
- [782] Item 7, MD&A — Corporate and Other Activities
- [783] Item 7, MD&A — Corporate and Other Activities
- [784] Item 7, MD&A — Corporate and Other Activities
- [785] Item 7, MD&A — Corporate and Other Activities
- [786] Item 7, MD&A — Corporate and Other Activities
- [787] Item 7, MD&A — Corporate and Other Activities
- [788] Item 7, MD&A — Corporate and Other Activities
- [789] Item 7, MD&A — Corporate and Other Activities
- [790] Item 7, MD&A — Corporate and Other Activities
- [791] Item 7, MD&A — Corporate and Other Activities
- [792] Item 7, MD&A — Corporate and Other Activities
- [793] Item 7, MD&A — Corporate and Other Activities
- [794] Item 7, MD&A — Corporate and Other Activities
- [795] Item 7, MD&A — Corporate and Other Activities
- [796] Item 7, MD&A — Corporate and Other Activities
- [797] Item 7, MD&A — Corporate and Other Activities
- [798] Item 7, MD&A — Corporate and Other Activities
- [799] Item 7, MD&A — Corporate and Other Activities
- [800] Item 7, MD&A — Corporate and Other Activities
- [801] Item 7, MD&A — Corporate and Other Activities
- [802] Item 7, MD&A — Corporate and Other Activities
- [803] Item 7, MD&A — Corporate and Other Activities
- [804] Item 7, MD&A — Corporate and Other Activities
- [805] Item 7, MD&A — Corporate and Other Activities
- [806] Item 7, MD&A — Corporate and Other Activities
- [807] Item 7, MD&A — Corporate and Other Activities
- [808] Item 7, MD&A — Corporate and Other Activities
- [809] Item 7, MD&A — Corporate and Other Activities
- [810] Item 7, MD&A — Corporate and Other Activities
- [811] Item 7, MD&A — Corporate and Other Activities
- [812] Item 7, MD&A — Corporate and Other Activities
- [813] Item 7, MD&A — Corporate and Other Activities
- [814] Item 7, MD&A — Corporate and Other Activities
- [815] Item 7, MD&A — Corporate and Other Activities
- [816] Item 7, MD&A — Corporate and Other Activities
- [817] Item 7, MD&A — Corporate and Other Activities
- [818] Item 7, MD&A — Corporate and Other Activities
- [819] Item 7, MD&A — Corporate and Other Activities
- [820] Item 7, MD&A — Corporate and Other Activities
- [821] Item 7, MD&A — Corporate and Other Activities
- [822] Item 7, MD&A — Corporate and Other Activities
- [823] Item 7, MD&A — Corporate and Other Activities
- [824] Item 7, MD&A — Corporate and Other Activities
- [825] Item 7, MD&A — Corporate and Other Activities
- [826] Item 7, MD&A — Corporate and Other Activities
- [827] Item 7, MD&A — Corporate and Other Activities
- [828] Item 7, MD&A — Corporate and Other Activities
- [829] Item 7, MD&A — Corporate and Other Activities
- [830] Item 7, MD&A — Corporate and Other Activities
- [831] Item 7, MD&A — Corporate and Other Activities
- [832] Item 7, MD&A — Corporate and Other Activities
- [833] Item 7, MD&A — Corporate and Other Activities
- [834] Item 7, MD&A — Corporate and Other Activities
- [835] Item 7, MD&A — Corporate and Other Activities
- [836] Item 7, MD&A — Corporate and Other Activities
- [837] Item 7, MD&A — Corporate and Other Activities
- [838] Item 7, MD&A — Corporate and Other Activities
- [839] Item 7, MD&A — Corporate and Other Activities
- [840] Item 7, MD&A — Corporate and Other Activities
- [841] Item 7, MD&A — Corporate and Other Activities
- [842] Item 7, MD&A — Corporate and Other Activities
- [843] Item 7, MD&A — Corporate and Other Activities
- [844] Item 7, MD&A — Corporate and Other Activities
- [845] Item 7, MD&A — Corporate and Other Activities
- [846] Item 7, MD&A — Corporate and Other Activities
- [847] Item 7, MD&A — Corporate and Other Activities
- [848] Item 7, MD&A — Corporate and Other Activities
- [849] Item 7, MD&A — Corporate and Other Activities
- [850] Item 7, MD&A — Corporate and Other Activities
- [851] Item 7, MD&A — Corporate and Other Activities
- [852] Item 7, MD&A — Corporate and Other Activities
- [853] Item 7, MD&A — Corporate and Other Activities
- [854] Item 7, MD&A — Corporate and Other Activities
- [855] Item 7, MD&A — Corporate and Other Activities
- [856] Item 7, MD&A — Corporate and Other Activities
- [857] Item 7, MD&A — Corporate and Other Activities
- [858] Item 7, MD&A — Corporate and Other Activities
- [859] Item 7, MD&A — Corporate and Other Activities
- [860] Item 7, MD&A — Corporate and Other Activities
- [861] Item 7, MD&A — Corporate and Other Activities
- [862] Item 7, MD&A — Corporate and Other Activities
- [863] Item 7, MD&A — Corporate and Other Activities
- [864] Item 7, MD&A — Corporate and Other Activities
- [865] Item 7, MD&A — Corporate and Other Activities
- [866] Item 7, MD&A — Corporate and Other Activities
- [867] Item 7, MD&A — Corporate and Other Activities
- [868] Item 7, MD&A — Corporate and Other Activities
- [869] Item 7, MD&A — Corporate and Other Activities
- [870] Item 7, MD&A — Corporate and Other Activities
- [871] Item 7, MD&A — Corporate and Other Activities
- [872] Item 7, MD&A — Corporate and Other Activities
- [873] Item 7, MD&A — Corporate and Other Activities
- [874] Item 7, MD&A — Corporate and Other Activities
- [875] Item 7, MD&A — Corporate and Other Activities
- [876] Item 7, MD&A — Corporate and Other Activities
- [877] Item 7, MD&A — Corporate and Other Activities
- [878] Item 7, MD&A — Corporate and Other Activities
- [879] Item 7, MD&A — Corporate and Other Activities
- [880] Item 7, MD&A — Corporate and Other Activities
- [881] Item 7, MD&A — Corporate and Other Activities
- [882] Item 7, MD&A — Corporate and Other Activities
- [883] Item 7, MD&A — Corporate and Other Activities
- [884] Item 7, MD&A — Corporate and Other Activities
- [885] Item 7, MD&A — Corporate and Other Activities
- [886] Item 7, MD&A — Corporate and Other Activities
- [887] Item 7, MD&A — Corporate and Other Activities
- [888] Item 7, MD&A — Corporate and Other Activities
- [889] Item 7, MD&A — Corporate and Other Activities
- [890] Item 7, MD&A — Corporate and Other Activities
- [891] Item 7, MD&A — Corporate and Other Activities
- [892] Item 7, MD&A — Corporate and Other Activities
- [893] Item 7, MD&A — Corporate and Other Activities
- [894] Item 7, MD&A — Corporate and Other Activities
- [895] Item 7, MD&A — Corporate and Other Activities
- [896] Item 7, MD&A — Corporate and Other Activities
- [897] Item 7, MD&A — Corporate and Other Activities
- [898] Item 7, MD&A — Corporate and Other Activities
- [899] Item 7, MD&A — Corporate and Other Activities
- [900] Item 7, MD&A — Corporate and Other Activities
- [901] Item 7, MD&A — Corporate and Other Activities
- [902] Item 7, MD&A — Corporate and Other Activities
- [903] Item 7, MD&A — Corporate and Other Activities
- [904] Item 7, MD&A — Corporate and Other Activities
- [905] Item 7, MD&A — Corporate and Other Activities
- [906] Item 7, MD&A — Corporate and Other Activities
- [907] Item 7, MD&A — Corporate and Other Activities
- [908] Item 7, MD&A — Corporate and Other Activities
- [909] Item 7, MD&A — Corporate and Other Activities
- [910] Item 7, MD&A — Corporate and Other Activities
- [911] Item 7, MD&A — Corporate and Other Activities
- [912] Item 7, MD&A — Corporate and Other Activities
- [913] Item 7, MD&A — Corporate and Other Activities
- [914] Item 7, MD&A — Corporate and Other Activities
- [915] Item 7, MD&A — Corporate and Other Activities
- [916] Item 7, MD&A — Corporate and Other Activities
- [917] Item 7, MD&A — Corporate and Other Activities
- [918] Item 7, MD&A — Corporate and Other Activities
- [919] Item 7, MD&A — Corporate and Other Activities
- [920] Item 7, MD&A — Corporate and Other Activities
- [921] Item 7, MD&A — Corporate and Other Activities
- [922] Item 7, MD&A — Corporate and Other Activities
- [923] Item 7, MD&A — Corporate and Other Activities
- [924] Item 7, MD&A — Corporate and Other Activities
- [925] Item 7, MD&A — Corporate and Other Activities
- [926] Item 7, MD&A — Corporate and Other Activities
- [927] Item 7, MD&A — Corporate and Other Activities
- [928] Item 7, MD&A — Corporate and Other Activities
- [929] Item 7, MD&A — Corporate and Other Activities
- [930] Item 7, MD&A — Corporate and Other Activities
- [931] Item 7, MD&A — Corporate and Other Activities
- [932] Item 7, MD&A — Corporate and Other Activities
- [933] Item 7, MD&A — Corporate and Other Activities
- [934] Item 7, MD&A — Corporate and Other Activities
- [935] Item 7, MD&A — Corporate and Other Activities
- [936] Item 7, MD&A — Corporate and Other Activities
- [937] Item 7, MD&A — Corporate and Other Activities
- [938] Item 7, MD&A — Corporate and Other Activities
- [939] Item 7, MD&A — Corporate and Other Activities
- [940] Item 7, MD&A — Corporate and Other Activities
- [941] Item 7, MD&A — Corporate and Other Activities
- [942] Item 7, MD&A — Corporate and Other Activities
- [943] Item 7, MD&A — Corporate and Other Activities
- [944] Item 7, MD&A — Corporate and Other Activities
- [945] Item 7, MD&A — Corporate and Other Activities
- [946] Item 7, MD&A — Corporate and Other Activities
- [947] Item 7, MD&A — Corporate and Other Activities
- [948] Item 7, MD&A — Corporate and Other Activities
- [949] Item 7, MD&A — Corporate and Other Activities
- [950] Item 7, MD&A — Corporate and Other Activities
- [951] Item 7, MD&A — Corporate and Other Activities
- [952] Item 7, MD&A — Corporate and Other Activities
- [953] Item 7, MD&A — Corporate and Other Activities
- [954] Item 7, MD&A — Corporate and Other Activities
- [955] Item 7, MD&A — Corporate and Other Activities
- [956] Item 7, MD&A — Corporate and Other Activities
- [957] Item 7, MD&A — Corporate and Other Activities
- [958] Item 7, MD&A — Corporate and Other Activities
- [959] Item 7, MD&A — Corporate and Other Activities
- [960] Item 7, MD&A — Corporate and Other Activities
- [961] Item 7, MD&A — Corporate and Other Activities
- [962] Item 7, MD&A — Corporate and Other Activities
- [963] Item 7, MD&A — Corporate and Other Activities
- [964] Item 7, MD&A — Corporate and Other Activities
- [965] Item 7, MD&A — Corporate and Other Activities
- [966] Item 7, MD&A — Corporate and Other Activities
- [967] Item 7, MD&A — Corporate and Other Activities
- [968] Item 7, MD&A — Corporate and Other Activities
- [969] Item 7, MD&A — Corporate and Other Activities
- [970] Item 7, MD&A — Corporate and Other Activities
- [971] Item 7, MD&A — Corporate and Other Activities
- [972] Item 7, MD&A — Corporate and Other Activities
- [973] Item 7, MD&A — Corporate and Other Activities
- [974] Item 7, MD&A — Corporate and Other Activities
- [975] Item 7, MD&A — Corporate and Other Activities
- [976] Item 7, MD&A — Corporate and Other Activities
- [977] Item 7, MD&A — Corporate and Other Activities
- [978] Item 7, MD&A — Corporate and Other Activities
- [979] Item 7, MD&A — Corporate and Other Activities
- [980] Item 7, MD&A — Corporate and Other Activities
- [981] Item 7, MD&A — Corporate and Other Activities
- [982] Item 7, MD&A — Corporate and Other Activities
- [983] Item 7, MD&A — Corporate and Other Activities
- [984] Item 7, MD&A — Corporate and Other Activities
- [985] Item 7, MD&A — Corporate and Other Activities
- [986] Item 7, MD&A — Corporate and Other Activities
- [987] Item 7, MD&A — Corporate and Other Activities
- [988] Item 7, MD&A — Corporate and Other Activities
- [989] Item 7, MD&A — Corporate and Other Activities
- [990] Item 7, MD&A — Corporate and Other Activities
- [991] Item 7, MD&A — Corporate and Other Activities
- [992] Item 7, MD&A — Corporate and Other Activities
- [993] Item 7, MD&A — Corporate and Other Activities
- [994] Item 7, MD&A — Corporate and Other Activities
- [995] Item 7, MD&A — Corporate and Other Activities
- [996] Item 7, MD&A — Corporate and Other Activities
- [997] Item 7, MD&A — Corporate and Other Activities
- [998] Item 7, MD&A — Corporate and Other Activities
- [999] Item 7, MD&A — Corporate and Other Activities
- [1000] Item 7, MD&A — Corporate and Other Activities
Analysis on 9/27/2026